Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/19/2019 11:55:21 AM - Followers: 76 - Board type: Free - Posts Today: 0

 
Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2
    2
    2
     
 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Statement of Changes in Beneficial Ownership (4) 01/21/2020 05:40:29 PM
VKTX News: Statement of Changes in Beneficial Ownership (4) 01/21/2020 05:36:23 PM
VKTX News: Viking Therapeutics to Present at Biotech Showcase 2020 01/06/2020 07:30:00 AM
VKTX News: Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic S... 11/19/2019 07:05:00 AM
VKTX News: Viking Therapeutics to Participate in Upcoming Investor Conferences 11/12/2019 07:30:00 AM
PostSubject
#1822   $VKTX good read https://news.squeezereport.com/short-squeeze/viking- whytestocks 12/19/19 11:55:20 AM
#1821   * * $VKTX Video Chart 12-09-2019 * * ClayTrader 12/09/19 05:55:34 PM
#1820   After couple of down days finally going up!!!!! now invest 11/21/19 11:34:46 AM
#1819   VKTX just broke 8 !!!! Still long way now invest 11/12/19 09:47:11 AM
#1818   RJ 41 target!! now invest 11/11/19 02:31:18 PM
#1817   Raymond James has it as a strong buy now invest 11/11/19 02:28:23 PM
#1816   $9-$11 targets sanderburwil 11/06/19 06:08:43 AM
#1815   * * $VKTX Video Chart 11-05-2019 * * ClayTrader 11/05/19 05:28:52 PM
#1814   News: $VKTX Viking Therapeutics Reports Third Quarter 2019 whytestocks 11/05/19 01:00:27 PM
#1813   News: $VKTX Viking Therapeutics to Present at 2019 whytestocks 09/25/19 12:30:23 PM
#1812   Here's a little article about VKTX. Nice to IRAHopeful 08/13/19 03:12:53 PM
#1810   Looking forward to getting the Phase 2b vk2809 greens12 08/07/19 07:52:07 PM
#1809   Impressed with the 5mg data and really hoping roadkilll 08/07/19 04:47:00 PM
#1808   Appreciate the CC post roadkilll 08/07/19 04:29:13 PM
#1807   Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript DMOST 08/06/19 10:29:08 PM
#1806   7/15/2019 22,751,462 shares short roadkilll 08/06/19 02:58:13 PM
#1805   VKTX: Awaiting Feedback from FDA regarding pre-IND submission; DMOST 08/03/19 11:55:23 PM
#1804   Totally agree with both the how long this BreakOnThrough 07/23/19 10:46:30 PM
#1803   vk5211 has huge potential , the great data greens12 07/22/19 07:38:38 PM
#1802   I haven’t been optimist, (in the short term BreakOnThrough 07/19/19 08:21:57 AM
#1801   Nice bounce today, should see 9.00 soon. Waiting greens12 07/16/19 11:53:22 AM
#1800   You’ve got that right!! BreakOnThrough 07/14/19 06:48:42 PM
#1799   A partnership announcement for Vk5211 would be nice:-). smallbio 07/14/19 04:18:21 PM
#1798   Thoughts on ringing the bell tomorrow..? Curious What BreakOnThrough 07/14/19 02:13:29 PM
#1797   CEO Meeting with the FDA mid summer for greens12 06/28/19 07:26:15 PM
#1796   VKTX ... Nada , Zilch[/col DMOST 06/26/19 02:28:37 PM
#1795   Is anything on the docket for VKTX anytime IRAHopeful 06/26/19 11:48:47 AM
#1794   How Viking Therapeutics Is Positioned DMOST 06/17/19 09:25:49 AM
#1793   What Analysts Recommend for CBAY and VKTX DMOST 06/14/19 01:36:28 PM
#1792   So much for your bones I suppose. Came Murph32 06/11/19 11:55:52 AM
#1791   Still holding strong, I'm here for the short greens12 06/08/19 01:25:21 PM
#1790   GO VKTX DMOST 05/14/19 03:12:13 PM
#1789   Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares? DMOST 05/14/19 03:09:42 PM
#1788   Dreaming! sorkin 05/08/19 06:13:36 AM
#1787   GILD or BMY or PFE will offer to guyguyguy 05/06/19 09:19:31 PM
#1786   28.7 million shares short!! sorkin 04/30/19 01:16:40 PM
#1785   Wow! Excellent analysis. I am intrigued. Sage7243 04/27/19 10:49:38 PM
#1784   That means absolutely nothing for the most part, Murph32 04/26/19 06:07:52 AM
#1783   VRTX needs another dosing 40mg/day in their trial! sorkin 04/24/19 11:54:34 AM
#1782   Largest institutional holder Fidelity management and research Sold sorkin 04/24/19 11:31:41 AM
#1781   All the Analysts covering this stock have Targets greens12 04/16/19 11:22:53 AM
#1780   $5 sorkin 04/15/19 01:09:10 PM
#1779   What Are Analysts Recommending for VKTX and ENTA? DMOST 04/15/19 09:22:20 AM
#1778   * * $VKTX Video Chart 04-12-2019 * * ClayTrader 04/12/19 05:22:10 PM
#1777   Sell the news and cashin sorkin 04/11/19 09:18:10 AM
#1776   Compared to Placebo, Absolute liver fat reduction with sorkin 04/11/19 09:16:55 AM
#1775   <This stock will be < $2 in 2-3 years> girlfriend 04/11/19 08:45:41 AM
#1774   Ha ha ha ha! Good one. Natureboy1 04/11/19 08:40:38 AM
#1773   This stock will be < $2 in 2-3 sorkin 04/11/19 08:27:54 AM
#1772   Viking Therapeutics Presents New Data from Phase 2 Paullee 04/11/19 07:27:41 AM
PostSubject